Takanori Hyo

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Little enhancement of meal‐induced glucagon‐like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls

Daisuke Yabe, Akira Kuroe, Soushou Lee et al. · Journal of Diabetes Investigation · 2010 · 89 citations · Full text

Medicine, Endocrinology, Clinical Nutrition +11

Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes

Daisuke Yabe, Koin Watanabe, Kenji Sugawara et al. · Journal of Diabetes Investigation · 2011 · 63 citations · Full text

Medicine, Endocrinology, Pharmacology +14

Lifestyle changes as a result of COVID‐19 containment measures: Bodyweight and glycemic control in patients with diabetes in the Japanese declaration of a state of emergency

Nagaaki Tanaka, Yoshiyuki Hamamoto, Yuri Kurotobi et al. · Journal of Diabetes Investigation · 2021 · 38 citations · Full text

Medicine, Health Behavior, Nutrition +13